Anti-(human Neonatal Fc Receptor) (human Monoclonal M281 .gamma.-1 Chain) Uses, Dosage, Side Effects and more
Anti-(human Neonatal Fc Receptor) (human Monoclonal M281 .gamma.-1 Chain) is under investigation in clinical trial NCT04119050 (Efficacy and Safety of M281 in Adults With Warm Autoimmune Hemolytic Anemia).
| Trade Name | Anti-(human Neonatal Fc Receptor) (human Monoclonal M281 .gamma.-1 Chain) |
| Generic | Nipocalimab |
| Nipocalimab Other Names | Immunoglobulin g1, anti-(human neonatal fc receptor) (human monoclonal m281 .gamma.-1 chain), disulfide with human monoclonal m281 .lambda.-chain, dimer, Nipocalimab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
